Galli, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.630
AS - Asia 2.295
EU - Europa 1.490
SA - Sud America 382
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 46
OC - Oceania 17
Totale 7.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.483
SG - Singapore 717
IT - Italia 617
CN - Cina 613
BR - Brasile 291
HK - Hong Kong 277
VN - Vietnam 263
GB - Regno Unito 177
SE - Svezia 124
BD - Bangladesh 123
RU - Federazione Russa 107
FI - Finlandia 104
DE - Germania 88
KR - Corea 84
FR - Francia 77
CA - Canada 58
NL - Olanda 43
ID - Indonesia 40
AR - Argentina 37
JP - Giappone 28
AT - Austria 27
MX - Messico 27
IN - India 23
TR - Turchia 23
IQ - Iraq 20
BG - Bulgaria 19
PL - Polonia 19
AU - Australia 17
MA - Marocco 17
EC - Ecuador 14
LT - Lituania 14
CR - Costa Rica 13
IL - Israele 13
ES - Italia 12
PK - Pakistan 12
CL - Cile 11
AE - Emirati Arabi Uniti 10
HN - Honduras 10
CO - Colombia 9
IE - Irlanda 9
ZA - Sudafrica 9
GT - Guatemala 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
JM - Giamaica 7
TW - Taiwan 7
UA - Ucraina 7
VE - Venezuela 7
EG - Egitto 6
HU - Ungheria 6
KG - Kirghizistan 6
PE - Perù 6
CZ - Repubblica Ceca 5
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
BE - Belgio 4
GR - Grecia 4
IR - Iran 3
PH - Filippine 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UZ - Uzbekistan 3
AG - Antigua e Barbuda 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GP - Guadalupe 2
GY - Guiana 2
JO - Giordania 2
NI - Nicaragua 2
PR - Porto Rico 2
RS - Serbia 2
SC - Seychelles 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 7.851
Salva come PNG Salva come JPEG
Città #
Santa Clara 510
Ashburn 500
Singapore 417
Hong Kong 274
San Jose 270
Hefei 238
Council Bluffs 164
Chandler 150
Fairfield 145
Ho Chi Minh City 98
London 95
Helsinki 92
Beijing 88
Nyköping 82
Seoul 82
New York 77
Milan 73
Los Angeles 72
Dallas 52
The Dalles 50
Moscow 49
Seattle 48
Chicago 46
Hanoi 46
Wilmington 45
Cambridge 41
Bologna 40
Buffalo 38
Houston 38
Woodbridge 37
Rome 36
Shanghai 28
Jakarta 27
Lauterbourg 27
São Paulo 24
Modena 23
Munich 23
Princeton 23
San Diego 22
Salt Lake City 21
Nuremberg 19
Atlanta 18
Florence 18
Tokyo 18
Brooklyn 17
Naples 17
North Bergen 17
Sofia 17
Ann Arbor 16
Kent 15
Da Nang 14
Southend 14
Columbus 13
Haiphong 13
Louisville 13
Orem 13
Rio de Janeiro 13
Boardman 12
Parma 12
Redondo Beach 12
Reggio Emilia 12
Toronto 12
Denver 11
Philadelphia 11
Ankara 10
Mexico City 10
Phoenix 10
Portsmouth 10
Vienna 10
Biên Hòa 9
Brasília 9
Elk Grove Village 9
Frankfurt am Main 9
Melbourne 9
Saint Augustine 9
Bremen 8
Casablanca 8
Des Moines 8
Dublin 8
Ksawerów 8
Lappeenranta 8
Porto Alegre 8
San José 8
Warsaw 8
Amsterdam 7
Bari 7
Dearborn 7
Dhaka 7
Montreal 7
Padova 7
Tampa 7
Washington 7
Cagliari 6
Chennai 6
Cleveland 6
Lahore 6
Miano 6
Palermo 6
Paris 6
Queens 6
Totale 4.838
Salva come PNG Salva come JPEG
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 379
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 365
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 317
EULAR guidelines on ANCA-associated vasculitis in the real life 301
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 273
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 267
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 255
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 252
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 241
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 240
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 223
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 221
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 214
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 205
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 204
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 200
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 199
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 198
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 196
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 192
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 192
What to Know About Biopsy Sampling and Pathology in Vasculitis? 187
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 182
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 180
Development of the Takayasu Arteritis Integrated Disease Activity Index 179
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 169
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 168
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 162
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 161
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 159
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 154
The management of large vessel vasculitides 154
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 152
Current management of giant cell arteritis and its complications 142
Reply 140
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 136
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 136
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 133
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 93
Totale 7.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022321 0 0 0 0 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20263.324 264 188 295 401 357 203 388 172 371 238 251 196
2026/20271.083 123 180 205 439 136 0 0 0 0 0 0 0
Totale 7.921